GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 ... Vir Biotechnology, Inc.May 7, 2021 GMT – Rolling review will evaluate sotrovimab in adults and adolescents with COVID-19 who do not require oxygen supplementation and who are at risk of progressing to severe COVID-19 – – Review will support a formal Marketing Authorization Application – – GSK and Vir continue discussions with global regulators to make sotrovimab available to patients with COVID-19 – ...